(Q54140677)

25 May 2018

editorial

0 references

title

Activated protein C resistance: What have we learned now that the dust has settled? (English)

1 reference

25 May 2018

activated protein C resistance

1 reference

1 reference

Petäjä JM

1

1 reference

25 May 2018

Griffin JH

series ordinal

2

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 December 1997

1 reference

25 May 2018

published in

Annals of Medicine

1 reference

25 May 2018

volume

29

1 reference

25 May 2018

issue

6

1 reference

25 May 2018

page(s)

469-472

1 reference

25 May 2018

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853899709007469

Molecular Genetics of Venous Thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709007469

Factor VLeiden and thrombophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709007469

Mutation in blood coagulation factor V associated with resistance to activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709007469

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709007469

Activated protein C resistance in ischemic stroke not due to factor V arginine506-->glutamine mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709007469

Reduced response to activated protein C is associated with increased risk for cerebrovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899709007469

10.3109/07853899709007469

21 January 2018

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018